1Department of Pediatric Critical Care, New York Presbyterian Hospital, Columbia University Medical Center, New York, NY.
2Department of Pediatric Critical Care, Columbia University College of Physicians and Surgeons, New York, NY.
3Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY.
4Department of Child Psychiatry, Weill Cornell Medical College, New York, NY.
5Department of Surgery, Columbia University College of Physicians and Surgeons, New York, NY.
6Department of Surgery, Columbia School of Nursing, Columbia University College of Physicians and Surgeons, New York, NY.
7Department of Pediatric Critical Care, Weill Cornell Medical College, New York, NY.
*See also p. 196.
This study was performed at New York Presbyterian Hospital, Columbia University Medical Center, New York, NY.
Dr. Gerber’s institution received funding (patent issued). Dr. Silver disclosed off-label product use of neuroleptic/antipsychotic medications that are used off label for symptoms of delirium. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]